29 March 2023
Versarien Plc
("Versarien" or the "Company")
Result of AGM
Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's Annual General Meeting held earlier today, all resolutions were duly passed.
The proxy votes cast were as follows:
Resolution | For |
| Against |
| Abstain |
1 - to receive the Directors' Report and the audited financial statements for the period ended 30 September 2022 together with the Independent Auditors' Report thereon
| 4,351,989 | 98.52% | 65,499 | 1.48% | 495,006 |
2 - reappointment of BDO LLP as auditor
| 4,504,639 | 96.85% | 146,516 | 3.15% | 261,339 |
3 - reappointment of Chris Leigh as a director
| 4,129,995 | 87.31% | 600,248 | 12.69% | 182,251 |
4 - reappoint Iain Gray as a director
| 4,282,792 | 91.72% | 386,392 | 8.28% | 243,310 |
5 - to authorise the directors to allot shares in the Company
| 4,071,554 | 90.97% | 403,977 | 9.03% | 436,963 |
6 - to disapply statutory pre-emption rights
| 3,905,578 | 88.97% | 484,416 | 11.03% | 522,500 |
7 - to authorise the Company to make market purchases of its own shares
| 4,190,578 | 92.29% | 350,223 | 7.71% | 371,693 |
For further information please contact:
Versarien Plc Diane Savory, Non-executive Chair Chris Leigh, Chief Financial Officer Stephen Hodge, Chief Technology Officer | c/o IFC
|
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Ewan Leggat, Adam Cowl | +44 (0)20 3470 0470 |
IFC Advisory (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen | +44 (0) 20 3934 6630 |
Notes to Editors:
About Versarien
The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK-based research and development centre driving recurring revenue growth through its innovative graphene product applications.
For further information please see: https://www.versarien.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.